FDA
approval
· 2022-08-25
FDA Approved: KETOROLAC TROMETHAMINE — Original Application (Camber Pharmaceuticals, Inc.)
Summary
FDA approves Camber Pharmaceuticals' original application for ketorolac tromethamine (an NSAID) for short-term management of acute pain, including postoperative…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)